Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
Plasmapheresis may facilitate soluble BCMA clearance and contribute to reversing primary resistance to anti-BCMA immunotherapy in myeloma (based on 1 patient who also got D-P(A)CE + pre-clinical studies).”
Title: Plasmapheresis facilitates soluble BCMA clearance and contributes to reversing primary resistance to anti-BCMA immunotherapy in multiple myeloma
Authors: Sven Neubert, Umair Munawar, Julia Mersi, Julia Noderer, Silvia Nerreter, Shilpa Kurian, Seungbin Han, Christina Verbruggen, Emma Besant, Nina Rein, Max Köppel, Johanna Lehmann, Tabea Köhler, Hannah Labinsky, Sigrun Häusl, Yoko Tamamushi, Xiang Zhou, Jule Pinter, Anna Laura Herzog, Kai Lopau, Elion Hoxha, Christoph Rummelt, Elena Gerhard-Hartmann, Andreas Rosenwald, Torsten Steinbrunn, Thomas Nerreter, Michael Hudecek, Hermann Einsele, Leo Rasche, K. Martin Kortüm, Johannes M. Waldschmidt
You can read the Full Article in Leukemia.
You can find more posts featuring Robert Orlowski on OncoDaily.
